Mid-Day Breakouts Report - Thursday, May 7th, 2015

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Monday, September 2, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - THURSDAY, MAY 7TH, 2015
Previous Mid Day Report Next Mid Day Report >>>

DOW 17944.28 102.3 (0.57%) | NASDAQ 4949.27 29.63 (0.60%) | S&P 500 2091.31 11.16 (0.54%)

Time of Screening : 5/7/2015 12:08:19 PM Report Released : 5/7/2015 1:25:38 PM
Price is: Above 52W High and Less Than 52W High but within 10% of the 52 Week High
Volume Is: At least 75% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

NONE OF OUR FEATURED STOCKS MET TODAY'S SCREENING CRITERIA FOR VOLUME AND PRICE ACTION.

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
ABMD - NASDAQ - HEALTH SERVICES - Medical Instruments & Supplies Abiomed Inc	$70.50	-3.34 -4.52%	$74.00	$76.90	-8.32%	664,763 118.08%	563,000
Most Recent Note for ABMD - 5/7/2015 12:13:38 PM Making its 3rd consecutive mid-day report appearance, pulling back following a 5/05/15 gap up and considerable gain for a new 52-week high. On 3/24/15 it gapped up on FDA approval of its heart pump. Reported strong Mar '15 earnings, its 3rd consecutive quarterly comparison above the +25% minimum guideline. Fundamental concerns remain as its up and down annual earnings (A criteria) history is not a match with the investment system's guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ACHC - NASDAQ - HEALTH SERVICES - Specialized Health Services Acadia Healthcare Inc	$67.10	+0.60 0.90%	$67.75	$74.09	-9.43%	415,498 82.28%	505,000
Most Recent Note for ACHC - 5/7/2015 12:19:00 PM Slumped below its 50 DMA line and completed a new Public Offering on 5/05/15. Needs gains above the 50 DMA for its outlook to improve. The 3 latest quarterly comparisons through Mar '15 showed strong earnings increases above the +25% minimum guideline (C criteria). Since tallying a loss in FY '11 its annual earnings (A criteria) have been strong.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ANTM - NYSE - HEALTH SERVICES - Health Care Plans Anthem, Inc	$156.70	-3.15 -1.97%	$159.45	$160.64	-2.45%	1,763,839 106.19%	1,661,000
Most Recent Note for ANTM - 5/7/2015 12:35:36 PM Challenged its 52-week high with a volume-driven gain on the prior session. Reported better earnings increases in the Dec '14 and Mar '15 quarters, but sub par sales revenues growth is a concern. Prior quarterly earnings history (C and A criteria) has been slow and steady, not a good match with the fact-based investment system's guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CDK - NASDAQ - COMPUTER SOFTWARE and SERVICES - Information Technology Service CDK Global, Inc	$49.23	+0.13 0.26%	$49.54	$49.80	-1.14%	1,051,586 103.00%	1,021,000
Most Recent Note for CDK - 5/7/2015 12:36:51 PM Consolidating near its 52-week high, finding recent support above its 50 DMA line. Prior mid-day reports cautioned members - "Reported earnings +13% on +5% sales revenues for the Mar '15 quarter. Prior quarterly earnings increases have not been strong and steady above the +25% minimum guideline (C criteria) and sub par sales revenues growth is a concern."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CLGX - NYSE - Finance-Mrtg&Rel Svc Corelogic Inc	$38.37	-0.16 -0.42%	$38.84	$40.74	-5.82%	445,540 82.51%	540,000
Most Recent Note for CLGX - 5/7/2015 12:38:15 PM Holding its ground near its 52-week high following a recent spurt of volume-driven gains. Prior mid-day reports cautioned members - "Reported earnings +156%* on +12% sales revenues for the Mar '15 quarter, but prior quarterly comparisons were below the +25% minimum guideline (C criteria)."*
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CMT - AMEX - CONSUMER NON-DURABLES - Rubber & Plastics Core Mlding Technologies	$22.58	+1.03 4.78%	$22.79	$22.00	2.64%	62,849 149.64%	42,000
Most Recent Note for CMT - 5/7/2015 12:40:29 PM Hitting another new 52-week high with today's volume-driven gain. Very extended from any sound base following an impressive streak of gains. Prior mid-day reports repeatedly cautioned members - "Reported earnings +55% on +18% sales for the Dec '14 quarter but fundamental concerns remain. Its quarterly and annual earnings (C and A criteria) history is not a good match with the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
COTY - NYSE - Cosmetics/Personal Care Coty Inc Cl A	$24.99	+0.77 3.18%	$25.64	$25.76	-2.99%	1,479,590 175.93%	841,000
Most Recent Note for COTY - 5/7/2015 12:43:01 PM Gapped up today, consolidating above its 50 DMA line and rallying near its 52-week high. Made gradual progress since last noted with caution in the 3/26/15 mid-day report - "Quarterly and annual earnings history (C and A criteria) is not a match with the fact-based investment system's fundamental guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
DATA - NYSE - HEALTH SERVICES - Medical Laboratories & Researc Tableau Software Cl A	$96.91	+0.16 0.16%	$97.93	$103.40	-6.28%	653,715 77.82%	840,000
Most Recent Note for DATA - 5/7/2015 12:46:01 PM Recently retreating from new all-time highs and testing support near its 50 DMA line. Churned above average volume and made little headway since last noted in the 4/17/15 mid-day report with caution - "Reported +75% sales revenues and a +110% earnings increase for the Dec '14 quarter. Fundamental concerns remain because its prior quarterly and annual earnings (C and A criteria) history has not been strong and steady."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
HAIN - NASDAQ - FOOD & BEVERAGE - Processed & Packaged Goods Hain Celestial Group	$60.51	+1.34 2.26%	$60.88	$66.35	-8.80%	806,607 92.18%	875,000
Most Recent Note for HAIN - 5/7/2015 12:50:08 PM Reported earnings +2% on +19% sales revenues for the Mar '15 quarter, below the +25% minimum earnings guideline (C criteria). Slumped badly on the prior session, and failed to find support after it violated its 50 DMA line with a volume-driven loss on 4/21/15. Shares split 2:1 on 12/30/14. Completed a Secondary Offering on 9/05/13. Annual earnings have improved following a downturn in FY '09 and FY '10 earnings (A criteria).
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
HRTG - NYSE - Insurance-Prop/Cas/Titl Heritage Insurance Holdings, Inc	$21.68	+0.37 1.74%	$22.07	$22.80	-4.91%	467,489 237.30%	197,000
Most Recent Note for HRTG - 5/7/2015 12:54:26 PM Rebounding back above its 50 DMA line helping its outlook improve with above average volume behind today's 3rd consecutive gain. The 3 latest quarterly comparisons through Mar '15 showed great sales revenue and earnings increases above the +25% minimum guideline (C criteria). Its limited annual earnings (A criteria) history is a concern with respect to the fact-based investment system's guidelines, and it is up from its $11 IPO on 5/23/14.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
IX - NYSE - FINANCIAL SERVICES - Credit Services Orix Corp Ads	$77.44	+1.04 1.36%	$77.45	$84.60	-8.46%	107,405 370.36%	29,000
Most Recent Note for IX - 5/7/2015 12:55:15 PM Went through a deep consolidation below its 200 DMA line and concerns remain as when long ago noted with caution in the 4/23/13 mid-day report - "Fundamentals fall short of the C and A criteria of the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
LMAT - NASDAQ - Medical-Products Lemaitre Vascular Inc	$9.77	-0.03 -0.31%	$9.80	$9.90	-1.31%	58,507 136.06%	43,000
Most Recent Note for LMAT - 5/7/2015 12:55:53 PM Perched at multi-year highs today and adding to an impressive streak of volume-driven gains. Prior mid-day reports cautioned members - "Sub par sales revenues growth and quarterly and annual earnings history (C and A criteria) is not a match with the fact-based investment system's guidelines. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MASI - NASDAQ - HEALTH SERVICES - Medical Instruments &; Supplies Masimo Corp	$35.17	+1.20 3.53%	$35.85	$35.39	-0.62%	403,573 110.57%	365,000
Most Recent Note for MASI - 5/7/2015 12:58:30 PM Hit a new 52-week high today. Reported improved earnings increases in the Dec '14 and Mar '15 quarters. Prior quarterly sales revenues growth has been sub par and earnings increases have not been a match with the fact-based investment system's guidelines (C and A criteria).
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MMS - NYSE - DIVERSIFIED SERVICES - Education & Training Services Maximus Inc	$65.46	+2.47 3.92%	$67.49	$69.04	-5.19%	727,802 130.90%	556,000
Most Recent Note for MMS - 5/7/2015 12:59:40 PM Reported earnings +2% on +10% sales revenues for the Mar '15 quarter, below the +25% minimum earnings guideline (C criteria). Gapped up today, rebounding above its 50 DMA line.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
NICE - NASDAQ - Computer Sftwr-Security Nice Ltd Adr	$61.05	+1.56 2.62%	$62.29	$61.92	-1.41%	153,110 80.58%	190,000
Most Recent Note for NICE - 5/7/2015 1:01:54 PM Gapped up today, rallying from support at its 50 DMA line and hitting a new 52-week high. Reported earnings +26% on +8% sales revenues for the Mar '15 quarter, but fundamental concerns remain. Sub par sales revenues growth is a concern and prior quarterly and annual earnings history is not a good match with the C and A criteria.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
PAYC - NYSE - COMPUTER SOFTWARE & SERVICES - Application Software Paycom Software, Inc	$33.81	+0.76 2.30%	$34.80	$35.86	-5.72%	969,426 268.54%	361,000
Most Recent Note for PAYC - 5/7/2015 1:07:28 PM Off earlier highs, it nearly challenged its 52-week high with today's 3rd volume-driven gain in the span of 4 sessions. Reported +300% earnings on +49% sales revenues for the Mar '15 quarter. Reported earnings of 6 cents per share versus a loss of 2 cents per share for the year-ago period ended December 31st. Limited history is a concern. Completed a Secondary Offering on 1/14/15. Technically, it has been forming a new base-on-base pattern. Last noted with caution in the 2/27/15 mid-day report - "Prior quarterly and annual earnings (A criteria) history has not been strong and steady."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
PCLN - NASDAQ - INTERNET - Internet Software & Services Priceline.com Inc	$1,223.83	-40.32 -3.19%	$1,227.89	$1,329.90	-7.98%	1,324,874 216.48%	612,000
Most Recent Note for PCLN - 5/7/2015 1:09:53 PM Gapped down today after reporting Mar '15 earnings news, testing support at its 50 DMA line. Went through a deep consolidation since dropped from the Featured Stocks list on 3/27/14 and an even deeper pullback after noted with caution in the 8/15/14 mid-day report. The 5/06/15 mid-day report cautioned members - "Faces some resistance due to overhead supply up through the $1,378 level. Reported earnings +23% on +19% sales revenues for the Dec '14 quarter, sequentially decelerating, and raising concerns while coming in below the +25% minimum guideline (C criteria)."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
PRAH - NASDAQ - HEALTH SERVICES - Medical Laboratories & Researc PRA Health Sciences, Inc	$29.41	+0.41 1.41%	$32.46	$31.99	-8.07%	357,557 183.36%	195,000
Most Recent Note for PRAH - 5/7/2015 1:13:36 PM Gapped up today and hit a new 52-week high, however it erased much of its early gain. Reported earnings +156% on +10% sales revenues for the Mar '15 quarter, and prior quarterly comparisons were also above the +25% minimum guideline (C criteria). Limited history is a concern (A criteria) and it is up from its $18 IPO on 11/13/14.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
TASR - NASDAQ - AEROSPACE/DEFENSE - Aerospace/Defense Products & Services T A S E R International	$32.47	-1.94 -5.64%	$33.35	$35.00	-7.23%	2,476,075 93.26%	2,655,000
Most Recent Note for TASR - 5/7/2015 1:14:54 PM Pulling back following a rally to new 52-week highs with 4 consecutive volume-driven gains. Prior mid-day reports repeatedly cautioned members - "Reported earnings +117% on +24% sales revenues for the Mar '15 quarter. It may be an interesting turnaround story, however its earnings history (C criteria) is not a match with the fact-based investment system's guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
USNA - NYSE - DRUGS - Drug Related Products U S A N A Health Science	$129.33	-11.19 -7.96%	$139.00	$140.99	-8.27%	100,627 122.72%	82,000
Most Recent Note for USNA - 5/7/2015 1:18:24 PM Abruptly retreating from its 52-week high, it gapped down today for a volume-driven loss erasing much of the prior session's considerable volume-driven gain. Reported +30% earnings on +20% sales revenues for the Mar '15 quarter but fundamental concerns remain. Found support near prior highs in the $118 area and well above its 50 DMA line during its consolidation after noted with caution in the 4/29/15 mid-day report - "Prior quarterly comparisons versus the year ago periods were not strong and steady above the +25% minimum guideline (C criteria). Ownership by top-rated funds rose from 226 in Jun '14 to 237 in Dec '14, a reassuring sign with respect to the I criteria. Its annual earnings (A criteria) growth rate has been improving since a downturn in FY '08."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
VRSK - NASDAQ - DIVERSIFIED SERVICES - research Verisk Analytics Cl A	$72.65	+0.16 0.22%	$72.99	$78.09	-6.97%	5,336,160 520.09%	1,026,000
Most Recent Note for VRSK - 5/7/2015 1:21:02 PM Found support after undercutting its 50 DMA line today. Pulling back since it hit a new 52-week high with a considerable "breakaway gap" when last noted with caution in the 4/29/15 mid-day report. There was an earlier breakaway gap on 2/25/15. Reported earnings +22% on +12% sales revenues for the Mar '15 quarter. Prior quarterly comparisons were below the +25% minimum earnings guideline (C criteria).
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
WD - NYSE - FINANCIAL - Property Management Walker & Dunlop Inc	$23.70	+0.40 1.72%	$23.99	$23.54	0.68%	387,652 116.76%	332,000
Most Recent Note for WD - 5/7/2015 1:23:40 PM Gapped up for a big gain on the prior session hitting new 52-week highs, and rallying further with today's 3rd consecutive volume-driven gain. The prior mid-day report cautioned members - "Reported greatly improved sales revenues and earnings increases in the Mar '15, and its strong Sep and Dec '14 quarters were previously noted. Up and down annual earnings (A criteria) history is a fundamental concern, making it not a good match with the fact-based investment system's guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
WX - NYSE - DRUGS - Drug Manufacturers - Other Wuxi Pharmatech Inc Ads	$43.97	-0.35 -0.79%	$44.95	$45.42	-3.19%	1,207,436 149.25%	809,000
Most Recent Note for WX - 5/7/2015 1:25:13 PM Holding its ground after the 5/04/15 mid-day report last cautioned members - "No resistance remains due to overhead supply after a considerable gap up and volume-driven gains last week for new 52-week highs. Fundamental concerns remain. Reported earnings +4% on +21% sales revenues for the Dec '14 quarter, and prior comparisons were below the +25% minimum earnings guideline (C criteria). This Chinese Medical - Research Equipment/Services firm's earnings history is not a match with the fact-based investment system's guidelines."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.